Rocksauce Fiery Hot Pain Relief

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available text.

Uses and Indications

This drug is indicated for the relief of discomfort associated with sore muscles and joints through the application of soothing heat. It is intended for use in individuals experiencing muscle and joint pain, providing a therapeutic effect to alleviate discomfort.

Dosage and Administration

Healthcare professionals are advised to apply the lotion liberally to the affected area of pain, ensuring thorough massage until the lotion is fully absorbed into the skin. This application should be repeated 3 to 4 times daily to achieve optimal therapeutic effects.

For storage, the lotion should be kept at a temperature range of 68° to 77°F (20° to 25°C) to maintain its efficacy.

Contraindications

Use of this product is contraindicated in the following situations:

• The product is not intended for use in children aged 5 years or younger.

• Administration should strictly adhere to the provided directions; any deviation is contraindicated.

• Heating, microwaving, or adding the product to hot water or any container that may cause splattering, leading to burns, is prohibited.

• Direct application to the eyes or mucus membranes is contraindicated.

• The product should not be ingested or placed in the nostrils.

• Application to wounds or damaged skin is not recommended.

Warnings and Precautions

For external use only; contact with eyes, mucous membranes, or broken skin must be avoided to prevent adverse effects.

It is imperative that this product is used strictly as directed. Users should refrain from the following actions while using this product: heating, microwaving, or adding it to hot water, as these practices may lead to splattering and potential burns. Additionally, the product should not be applied to the eyes or directly on mucous membranes, ingested, or placed in the nostrils. It is also contraindicated for application on wounds or damaged skin.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Users are advised to discontinue use and consult a healthcare professional if any irritation occurs. Pregnant or breastfeeding individuals should seek guidance from a healthcare provider prior to use. Furthermore, individuals with sensitive skin are encouraged to consult a physician before using this product.

Side Effects

Patients should be aware that the product is for external use only and must avoid contact with the eyes, mucous membranes, or broken skin. In clinical practice, it is important to consult a doctor and discontinue use if any irritation occurs.

Additionally, patients are advised to seek guidance from a health professional before using the product if they are pregnant or breastfeeding. Those with sensitive skin should also consult a doctor prior to use to ensure safety and minimize the risk of adverse reactions.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Rocksauce Fiery Hot Pain Relief (methyl salicylate, menthol, capsaicin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 5 years of age should not use this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The potential risks and benefits must be carefully considered, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and breastfeeding.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication if they are breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

There is currently no available information regarding teratogenic effects, non-teratogenic effects, or any specific findings in nonclinical toxicology studies. Additionally, no data has been provided concerning animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact the Poison Control Center in the event of accidental ingestion. It is important to emphasize that this product is not intended for use in children aged 5 years or younger.

Patients should be instructed to use the product strictly as directed and to avoid any misuse. They should be cautioned against heating the product, microwaving it, or adding it to hot water, as these actions may lead to splattering and burns. Additionally, patients must be informed not to apply the product to the eyes, directly on mucous membranes, or to ingest it by mouth or place it in the nostrils. The product should not be applied to wounds or damaged skin.

Healthcare providers should recommend that patients consult a doctor and discontinue use if any irritation occurs. It is also advisable for patients to seek guidance from a health professional before using the product if they are pregnant or breastfeeding. Furthermore, patients with sensitive skin should be encouraged to consult a doctor prior to use.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled temperature range of 68° to 77°F (20° to 25°C) to maintain its integrity and efficacy. Proper storage conditions should be ensured to prevent any degradation of the product.

Additional Clinical Information

The product is administered topically, with patients advised to apply the lotion liberally to the area of pain and massage until absorbed into the skin. This application can be repeated 3-4 times daily.

Clinicians should counsel patients to consult a doctor and discontinue use if irritation occurs. Additionally, patients who are pregnant or breastfeeding should seek advice from a health professional before use. Those with sensitive skin are also encouraged to consult a doctor prior to application. It is important to keep the product out of reach of children, and in the event of accidental ingestion, medical help should be sought immediately or the Poison Control Center should be contacted.

Drug Information (PDF)

This file contains official product information for Rocksauce Fiery Hot Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)